SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001144204-18-006679
Filing Date
2018-02-08
Accepted
2018-02-08 17:21:24
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D tv485324_sc13d.htm SC 13D 35958
  Complete submission text file 0001144204-18-006679.txt   37418
Mailing Address 2655 FIRST STREET SUITE 250 SIMI VALLEY CA 93065
Business Address 2655 FIRST STREET SUITE 250 SIMI VALLEY CA 93065 805-955-4190
INNOVATE BIOPHARMACEUTICALS, INC. (Subject) CIK: 0001551986 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-90111 | Film No.: 18586693
SIC: 2834 Pharmaceutical Preparations

Mailing Address 8480 HONEYCUTT RD, SUITE 200 RALEIGH NC 27615
Business Address
Prior Christopher P. (Filed by) CIK: 0001721749 (see all company filings)

Type: SC 13D